Finding New Biological Clues in Hard-to-Treat Migraine
Part of Brain & nervous system clinical trials.
This study looks for new biological markers in people whose migraines don't respond to standard treatments. It aims to better understand why some migraines are hard to treat and may help guide future therapies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have been diagnosed with episodic or chronic migraine
- You have tried at least three different migraine prevention medicines without success
- You have never used CGRP-blocking drugs like Aimovig, Emgality, or Ajovy
- You do not have other serious health conditions, chronic pain, or substance abuse problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at the chemical changes in the blood of people with migraine. It aims to better understand the disease and may help find new treatments. You may qualify if you have episodic or chronic migraine and have not tried CGRP-targeting drugs.
This trial is testing new approaches for people whose migraines haven't improved with multiple preventive treatments. The goal is to find better options for those with hard-to-treat migraine.
This study looks at how preventive treatments (botulinum toxin type A or anti-CGRP antibodies) affect thinking, memory, and quality of life in adults with hard-to-treat migraines. It aims to see if these treatments help more than just reducing headache days.
This study is building a database to learn more about migraine drugs. It may help researchers find better treatments for people with episodic or chronic migraine.
This study looks at how a type of immune cell (regulatory T cells) might help control migraine attacks. Researchers want to understand if your immune system plays a role in keeping migraines under control.
This study tracks how well new migraine medications (like Aimovig, Emgality, Ajovy, Vyepti, Qulipta, and Nurtec) work in everyday use. It may help you and your doctor understand if these treatments are a good option for your migraines.
Hear when a new Migraine Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.